Literature DB >> 9514487

Reattachment rate of human retinal pigment epithelium to layers of human Bruch's membrane.

L V Del Priore1, T H Tezel.   

Abstract

OBJECTIVES: To determine the reattachment rate of human retinal pigment epithelium (RPE) to different layers of human Bruch's membrane (BM).
METHODS: Explants of BM were prepared from 10 human cadaver eyes by removing native RPE. The RPE basal lamina, inner collagenous layer, elastin layer, and outer collagenous layer were exposed by sequentially removing each apical layer by mechanical or enzymatic means. First-passage human RPE was plated onto the surface and the RPE reattachment rate to each layer of BM was determined.
RESULTS: Retinal pigment epithelial cell reattachment was highest to the inner aspects of BM and decreased as deeper layers of BM were exposed (ie, reattachment rate to basal lamina was higher than to the inner collagenous layer, which was higher than to the elastin layer, which was higher than to the outer collagenous layer). The reattachment rate to the inner collagenous layer, elastin layer, and outer collagenous layer harvested from elderly donors (age >60 years) was less than the reattachment rate to corresponding layers harvested from younger (age <50 years) donors.
CONCLUSIONS: Retinal pigment epithelial cell reattachment depends on the anatomical layer of BM present in the host tissue. Age-related changes in BM may interfere with RPE reattachment. Our observations may have implications for understanding the pathogenesis of age-related macular degeneration and its potential treatment with RPE transplantation techniques.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514487     DOI: 10.1001/archopht.116.3.335

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  20 in total

1.  Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results.

Authors:  P E Stanga; A Kychenthal; F W Fitzke; A S Halfyard; R Chan; A C Bird; G W Aylward
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  [RPE transplantation: the challenges and the future].

Authors:  M E Boulton
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

3.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

4.  Abundant lipid and protein components of drusen.

Authors:  Lan Wang; Mark E Clark; David K Crossman; Kyoko Kojima; Jeffrey D Messinger; James A Mobley; Christine A Curcio
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

Review 5.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 6.  Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.

Authors:  Imran Bhutto; Gerard Lutty
Journal:  Mol Aspects Med       Date:  2012-04-21

7.  Retinal pigment epithelium resurfacing of aged submacular human Bruch's membrane.

Authors:  Vamsi K Gullapalli; Ilene K Sugino; Yancy Van Patten; Sumit Shah; Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membrane.

Authors:  Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 9.  Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.

Authors:  Christine A Curcio; Mark Johnson; Jiahn-Dar Huang; Martin Rudolf
Journal:  Prog Retin Eye Res       Date:  2009-08-19       Impact factor: 21.198

Review 10.  Human pluripotent stem cell-derived retinal pigmented epithelium in retinal treatment: from bench to bedside.

Authors:  Maryam Parvini; Leila Satarian; Kazem Parivar; Mohammad Javan; Mahdi Tondar; Sajjad Ahmad; Hossein Baharvand
Journal:  Mol Neurobiol       Date:  2014-04-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.